AbbVie Appears Ready To Move Higher
AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...
Future Market Insights9h
Extremity Tissue Expanders Market Dominated by Key Players, Accounting for 60% of Global Share
Top five players, including Mentor Worldwide LLC and Allergan PLC, control 60% of the extremity tissue expanders market.
Hosted on MSN13h
2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Procedures in Seniors
There was a notable decrease in common ophthalmic procedures among Medicare beneficiaries during the first year of the ...
Natrelle Returns to Demystify Breast Reconstruction With Unique, Inspiring Stories in New Campaign That Celebrates ‘Every Curve, Every Shape’
Casting is open. Allergan Aesthetics is on the search for women to inspire women as one of the Faces of Natrelle. The ...
globalcosmeticsnews1d
Allergan Aesthetics Introduces New AMI Training Centers Across the US
Allergan Aesthetics, an AbbVie company, has unveiled plans to open three new Allergan Medical Institute (AMI) Training ...
People’s Pharmacy: Here’s the latest FDA update on breast implant illness
The safety of breast implants has been controversial for decades. On February 6, 2025, the Food and Drug Administration ...
Science-Based Medicine5d
Botulinum Toxin: A tale of medicine, beauty, and danger
When used responsibly botulinum toxin is very safe, but patients should be especially vigilant about cosmetic treatments done ...
Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, today announced Allergan Medical Institute (AMI) will open three new ...
Scandal of the women harmed by medical implants who are BANNED from seeking compensation
Emma-Louise Lucas, a mother of one from Manchester, at just 31 received the shocking news that she had a rare type of cancer ...
BioSpace8d
AbbVie Gets FDA Approval for New Antibiotic in the Face of Rising Resistance
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
Hosted on MSN13d
MedPharm appoints Bill Humphries as new CEO
MedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth. The move ...
Mayo News16d
Allergan and Pfizer to merge
Alternatively, you can pay €0.50 per article, capped at €1 per day. EXACTLY a year after being bought for $66 billion, it has been announced that Allergan is to be merged with global pharmaceutical ...